Entinostat
CAS No. 209783-80-2
Entinostat ( MS-275;SNDX-275;MS 275;SNDX 275 )
Catalog No. M13310 CAS No. 209783-80-2
A potent and selective class I HDACs inhibitor with IC50 of 243/453/248 nM for HDAC1/2/3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 45 | In Stock |
|
25MG | 65 | In Stock |
|
50MG | 81 | In Stock |
|
100MG | 113 | In Stock |
|
200MG | 174 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEntinostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective class I HDACs inhibitor with IC50 of 243/453/248 nM for HDAC1/2/3.
-
DescriptionA potent and selective class I HDACs inhibitor with IC50 of 243/453/248 nM for HDAC1/2/3; no inhibition on HDAC8/4/5/7/9/6/10 (IC50>10 uM); induces accumulation of p21WAF1/CIP1 and gelsolin in K562 cell; reduce S-phase cells and induce G1-phase cells in A2780 cell.Breast Cancer Phase 3 Clinical
-
SynonymsMS-275;SNDX-275;MS 275;SNDX 275
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC1;HDAC3
-
Research AreaCancer
-
IndicationBreast Cancer
Chemical Information
-
CAS Number209783-80-2
-
Formula Weight376.41
-
Molecular FormulaC21H20N4O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(OCC1=CC=CN=C1)NCC2=CC=C(C(NC3=CC=CC=C3N)=O)C=C2
-
Chemical NameCarbamic acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3-pyridinylmethyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Saito A, et al. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4592-7.
2. Lauffer BE, et al. J Biol Chem. 2013 Sep 13;288(37):26926-43.
3. Rosato RR, et al. Cancer Res, 2003, 63(13), 3637-3645.
2. Lauffer BE, et al. J Biol Chem. 2013 Sep 13;288(37):26926-43.
3. Rosato RR, et al. Cancer Res, 2003, 63(13), 3637-3645.
molnova catalog
related products
-
SBHA
SBHA (suberohydroxamic acid) is a Histone deacetylase (HDAC) inhibitor. HDAC is required for transcriptional modulation, cell cycle regulation and development.
-
Givinostat
Givinostat or gavinostat, aslo known as ITF2357, is a potent and orally active histone deacetylase inhibitor with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities.
-
T326
A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.